Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Uncertainty | 4 | 2019 | 1888 | 0.81 | Why? |
| Neutralization Tests | 4 | 2021 | 6698 | 0.76 | Why? |
| Laboratories, Hospital | 3 | 2018 | 489 | 0.75 | Why? |
| Immunoenzyme Techniques | 1 | 2020 | 448 | 0.70 | Why? |
| Data Interpretation, Statistical | 2 | 2018 | 657 | 0.64 | Why? |
| Leukocyte L1 Antigen Complex | 1 | 2018 | 238 | 0.64 | Why? |
| Quality Control | 5 | 2019 | 628 | 0.58 | Why? |
| Clinical Laboratory Techniques | 9 | 2020 | 23402 | 0.58 | Why? |
| Glycoproteins | 1 | 2020 | 615 | 0.57 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2018 | 449 | 0.54 | Why? |
| Blood Specimen Collection | 1 | 2018 | 387 | 0.53 | Why? |
| Pancreatic Neoplasms | 2 | 2019 | 609 | 0.53 | Why? |
| Reference Values | 4 | 2019 | 795 | 0.47 | Why? |
| Blood Cell Count | 1 | 2018 | 1101 | 0.47 | Why? |
| Antibodies, Viral | 11 | 2021 | 51949 | 0.46 | Why? |
| Antibodies, Neutralizing | 4 | 2021 | 25288 | 0.42 | Why? |
| Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 7868 | 0.41 | Why? |
| Interdisciplinary Communication | 1 | 2018 | 1425 | 0.40 | Why? |
| Immunoglobulin A | 2 | 2021 | 3567 | 0.38 | Why? |
| Luminescent Measurements | 4 | 2021 | 924 | 0.35 | Why? |
| Accreditation | 3 | 2018 | 203 | 0.35 | Why? |
| Antibody Formation | 1 | 2021 | 4038 | 0.34 | Why? |
| Immunity | 1 | 2019 | 2651 | 0.33 | Why? |
| Spondylitis, Ankylosing | 2 | 2021 | 231 | 0.33 | Why? |
| Clinical Decision-Making | 2 | 2018 | 3755 | 0.33 | Why? |
| Proteomics | 1 | 2018 | 2481 | 0.32 | Why? |
| Feces | 1 | 2018 | 4235 | 0.28 | Why? |
| Immunoglobulin G | 6 | 2021 | 21571 | 0.27 | Why? |
| Serologic Tests | 3 | 2021 | 4359 | 0.24 | Why? |
| Inflammatory Bowel Diseases | 1 | 2018 | 3209 | 0.22 | Why? |
| Sphingolipidoses | 1 | 2019 | 1 | 0.21 | Why? |
| Reference Standards | 3 | 2019 | 1163 | 0.21 | Why? |
| Inflammation | 3 | 2020 | 13255 | 0.20 | Why? |
| Nephelometry and Turbidimetry | 1 | 2018 | 25 | 0.20 | Why? |
| Sphingolipids | 1 | 2019 | 59 | 0.19 | Why? |
| C-Peptide | 1 | 2019 | 77 | 0.19 | Why? |
| Centrifugation | 1 | 2018 | 42 | 0.19 | Why? |
| Pre-Analytical Phase | 1 | 2018 | 36 | 0.18 | Why? |
| Reproducibility of Results | 6 | 2020 | 11304 | 0.18 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.18 | Why? |
| Physicians | 1 | 2018 | 4214 | 0.18 | Why? |
| Protein Subunits | 1 | 2021 | 755 | 0.18 | Why? |
| Molecular Weight | 1 | 2018 | 249 | 0.17 | Why? |
| Tumor Microenvironment | 1 | 2019 | 264 | 0.16 | Why? |
| Thyrotropin | 1 | 2018 | 262 | 0.16 | Why? |
| Immunoassay | 3 | 2021 | 4485 | 0.16 | Why? |
| Laboratory Personnel | 1 | 2018 | 126 | 0.16 | Why? |
| Serum | 1 | 2018 | 294 | 0.16 | Why? |
| Dried Blood Spot Testing | 1 | 2019 | 383 | 0.15 | Why? |
| Hemolysis | 1 | 2018 | 283 | 0.15 | Why? |
| Pancreas | 1 | 2019 | 398 | 0.14 | Why? |
| Blood Chemical Analysis | 1 | 2019 | 541 | 0.14 | Why? |
| Area Under Curve | 2 | 2020 | 2564 | 0.14 | Why? |
| Humans | 34 | 2021 | 930598 | 0.13 | Why? |
| Calgranulin A | 1 | 2014 | 74 | 0.13 | Why? |
| Calgranulin B | 1 | 2014 | 144 | 0.13 | Why? |
| Decision Support Systems, Clinical | 1 | 2019 | 551 | 0.13 | Why? |
| Warfarin | 1 | 2018 | 402 | 0.13 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.13 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.13 | Why? |
| Saliva | 2 | 2021 | 4679 | 0.12 | Why? |
| Troponin I | 1 | 2020 | 1298 | 0.12 | Why? |
| Kinetics | 1 | 2020 | 3238 | 0.11 | Why? |
| Transforming Growth Factor beta | 1 | 2014 | 363 | 0.11 | Why? |
| Algorithms | 2 | 2019 | 7346 | 0.11 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.11 | Why? |
| Immunoglobulin M | 4 | 2021 | 9091 | 0.11 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 11367 | 0.11 | Why? |
| Sensitivity and Specificity | 6 | 2021 | 22971 | 0.10 | Why? |
| Insulin | 1 | 2019 | 1316 | 0.10 | Why? |
| Female | 16 | 2021 | 380317 | 0.10 | Why? |
| Male | 15 | 2021 | 367725 | 0.09 | Why? |
| Diagnostic Tests, Routine | 1 | 2020 | 2643 | 0.09 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.09 | Why? |
| Seroepidemiologic Studies | 2 | 2021 | 10017 | 0.09 | Why? |
| Hydrocortisone | 1 | 2018 | 1790 | 0.09 | Why? |
| Tumor Necrosis Factor-alpha | 1 | 2018 | 2483 | 0.09 | Why? |
| Immunotherapy | 1 | 2021 | 2421 | 0.08 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.08 | Why? |
| Aged | 9 | 2021 | 215776 | 0.08 | Why? |
| RNA, Messenger | 1 | 2021 | 5131 | 0.08 | Why? |
| Macrophages | 1 | 2019 | 2784 | 0.08 | Why? |
| Health Personnel | 3 | 2021 | 29646 | 0.08 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.08 | Why? |
| Laboratories | 1 | 2019 | 2858 | 0.08 | Why? |
| Young Adult | 4 | 2021 | 93724 | 0.08 | Why? |
| Chromatography, Liquid | 2 | 2019 | 640 | 0.07 | Why? |
| Adult | 11 | 2021 | 244371 | 0.07 | Why? |
| Guidelines as Topic | 1 | 2017 | 2844 | 0.07 | Why? |
| Longitudinal Studies | 1 | 2020 | 9893 | 0.07 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.07 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.07 | Why? |
| Patient Safety | 1 | 2019 | 4885 | 0.07 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2019 | 4545 | 0.07 | Why? |
| Antigens, Viral | 1 | 2021 | 6298 | 0.06 | Why? |
| Atrial Fibrillation | 1 | 2018 | 2320 | 0.06 | Why? |
| Biomarkers | 4 | 2020 | 23361 | 0.06 | Why? |
| C-Reactive Protein | 1 | 2020 | 7972 | 0.06 | Why? |
| Tandem Mass Spectrometry | 2 | 2019 | 1031 | 0.06 | Why? |
| Immunosuppressive Agents | 1 | 2021 | 6331 | 0.06 | Why? |
| Serology | 1 | 2021 | 60 | 0.06 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2019 | 5837 | 0.06 | Why? |
| Specimen Handling | 1 | 2018 | 6190 | 0.05 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.05 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.05 | Why? |
| Animals | 2 | 2020 | 78931 | 0.05 | Why? |
| Lysosomal Storage Diseases | 1 | 2019 | 30 | 0.05 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 13720 | 0.05 | Why? |
| Case-Control Studies | 1 | 2018 | 17671 | 0.05 | Why? |
| Child | 4 | 2021 | 70012 | 0.05 | Why? |
| Cytochrome P450 Family 4 | 1 | 2018 | 7 | 0.05 | Why? |
| Pyrin | 1 | 2018 | 15 | 0.05 | Why? |
| Cytochrome P-450 CYP2C9 | 1 | 2018 | 25 | 0.05 | Why? |
| Antibodies, Monoclonal | 1 | 2018 | 8041 | 0.05 | Why? |
| Italy | 5 | 2021 | 38444 | 0.05 | Why? |
| Vitamin K Epoxide Reductases | 1 | 2018 | 32 | 0.05 | Why? |
| HLA-B27 Antigen | 1 | 2018 | 48 | 0.05 | Why? |
| Pregnancy | 1 | 2020 | 23879 | 0.04 | Why? |
| Blood Sedimentation | 1 | 2020 | 508 | 0.04 | Why? |
| Biotechnology | 1 | 2021 | 444 | 0.04 | Why? |
| Calibration | 1 | 2018 | 307 | 0.04 | Why? |
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2018 | 229 | 0.04 | Why? |
| Nucleocapsid | 1 | 2021 | 734 | 0.04 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.04 | Why? |
| Quality Assurance, Health Care | 1 | 2021 | 596 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.04 | Why? |
| International Normalized Ratio | 1 | 2018 | 300 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Smad4 Protein | 1 | 2014 | 15 | 0.04 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.04 | Why? |
| Haplotypes | 1 | 2018 | 853 | 0.03 | Why? |
| Promoter Regions, Genetic | 1 | 2018 | 823 | 0.03 | Why? |
| Calcium Signaling | 1 | 2014 | 133 | 0.03 | Why? |
| China | 1 | 2020 | 50654 | 0.03 | Why? |
| Cluster Analysis | 1 | 2021 | 3001 | 0.03 | Why? |
| Alleles | 1 | 2018 | 1557 | 0.03 | Why? |
| Arthritis, Psoriatic | 1 | 2018 | 625 | 0.03 | Why? |
| Data Collection | 1 | 2021 | 1769 | 0.03 | Why? |
| Epithelial-Mesenchymal Transition | 1 | 2014 | 242 | 0.03 | Why? |
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 372 | 0.03 | Why? |
| Decision Support Techniques | 1 | 2019 | 903 | 0.03 | Why? |
| Limit of Detection | 1 | 2019 | 2698 | 0.03 | Why? |
| Glycated Hemoglobin A | 1 | 2018 | 1316 | 0.03 | Why? |
| Proteolysis | 1 | 2014 | 751 | 0.03 | Why? |
| Pilot Projects | 1 | 2021 | 5182 | 0.02 | Why? |
| Plasma | 1 | 2019 | 1809 | 0.02 | Why? |
| Monitoring, Physiologic | 1 | 2020 | 1956 | 0.02 | Why? |
| Infant, Newborn | 2 | 2021 | 23105 | 0.02 | Why? |
| Point-of-Care Testing | 1 | 2021 | 2782 | 0.02 | Why? |
| Precision Medicine | 1 | 2018 | 1477 | 0.02 | Why? |
| Infant | 2 | 2021 | 30274 | 0.02 | Why? |
| Symptom Assessment | 1 | 2021 | 4967 | 0.02 | Why? |
| Acute Disease | 1 | 2020 | 6029 | 0.02 | Why? |
| NF-kappa B | 1 | 2014 | 1301 | 0.02 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.02 | Why? |
| Child, Preschool | 2 | 2021 | 36283 | 0.02 | Why? |
| Odds Ratio | 1 | 2018 | 5861 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Genotype | 1 | 2018 | 4697 | 0.02 | Why? |
| Electronic Health Records | 1 | 2019 | 3492 | 0.02 | Why? |
| Cell Line, Tumor | 1 | 2014 | 3608 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2018 | 3607 | 0.02 | Why? |
| Decision Making | 1 | 2019 | 3132 | 0.02 | Why? |
| Peptide Fragments | 1 | 2014 | 2075 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Contact Tracing | 1 | 2021 | 8448 | 0.01 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.01 | Why? |
| Prevalence | 1 | 2020 | 25773 | 0.01 | Why? |
| Protein Binding | 1 | 2014 | 11430 | 0.01 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
Padoan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(172)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(106)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_